$Tiger Brokers(TIGR)$ Tiger Brokers’ interest expenses for Q3 2025 were $21.9 million, up 39.8% from $15.7 million in the same period last year. Still bullish.
$SMIC(00981)$ Nice little gain on SMIC! Capitalizing on chip boom & homegrown substitution. Q3 capacity hit 95.8% — production lines are packed! Snagged the Contra688 cash vouchers too, free money feels good. Staying long for the next lift-off!
$Tesla Motors(TSLA)$ Elon Musk and his xAI team have built the world's largest and most powerful AI training supercomputer. It’s an epic arms race. Put simply: Want Musk and his genius team working for you? Then holding a share of $TSLA might just make your day.
$SANHUA(02050)$ Capitalizing on its HVAC component supremacy, Sanhua is aggressively diversifying into NEV and robotics sectors, demonstrating impressive technological scalability that appeals to value-oriented investors.
$VanEck Semiconductor ETF(SMH)$ ETF delivers $447.35 gains at $271.50 (vs $262.73 entry)! Semiconductor sector rallies on AI boom and demand recovery. This ETF smartly captures the chip industry renaissance.
$ProShares UltraPro Dow30(UDOW)$ Trump is paying the price for his earlier “stubborn” policies. After the hundred-day plan, trade talks stalled, Russia-Ukraine negotiations faced setbacks, and US debt pressure remains high. Today, the US International Trade Court demanded the removal of tariffs imposed under an alleged misuse of the International Emergency Economic Powers Act (IEEPA). For the market, the key question is whether this passive easing is real or not. The court halting tariffs can be seen as a phased, indirect easing. If this decision holds, asset performance may shift toward “lower taxes↑, lower tariffs↓.” US debt pressure will increase due to declining tariff revenue, but this is positive for the dollar and US stocks.
$HUA HONG SEMI(01347)$ In the mid to long run, Hua Hong basically moves in lockstep with HK Semiconductor. Their gains since the start of the year are almost the same. If HK Semi takes off, Hua Hong’s gonna follow for sure. I’m holding tight and just waiting for it to ride the wave and bring in the profits!
$Zai Lab Ltd(ZLAB)$ delivers an impressive performance! With a 50% YoY revenue growth in 2024 and a remarkable 66% surge in Q4, the momentum of this innovative biopharma company is undeniable. Looking ahead, the company projects $5.6-$5.9 billion in revenue for 2025—strong growth ahead!